<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2019//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_190101.dtd">
<PubmedArticleSet>
  <PubmedArticle>
    <MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated">
      <PMID Version="1">35238494</PMID>
      <DateCompleted>
        <Year>2022</Year>
        <Month>04</Month>
        <Day>20</Day>
      </DateCompleted>
      <DateRevised>
        <Year>2022</Year>
        <Month>04</Month>
        <Day>21</Day>
      </DateRevised>
      <Article PubModel="Print-Electronic">
        <Journal>
          <ISSN IssnType="Electronic">2162-3279</ISSN>
          <JournalIssue CitedMedium="Internet">
            <Volume>12</Volume>
            <Issue>4</Issue>
            <PubDate>
              <Year>2022</Year>
              <Month>Apr</Month>
            </PubDate>
          </JournalIssue>
          <Title>Brain and behavior</Title>
          <ISOAbbreviation>Brain Behav</ISOAbbreviation>
        </Journal>
        <ArticleTitle>KinesioTaping after botulinum toxin type A for cervical dystonia in adult patients.</ArticleTitle>
        <Pagination>
          <StartPage>e2541</StartPage>
          <MedlinePgn>e2541</MedlinePgn>
        </Pagination>
        <ELocationID EIdType="pii" ValidYN="Y">e2541</ELocationID>
        <ELocationID EIdType="doi" ValidYN="Y">10.1002/brb3.2541</ELocationID>
        <Abstract>
          <AbstractText Label="INTRODUCTION" NlmCategory="BACKGROUND">Studies explored physiotherapeutic approaches in cervical dystonia (CD) patients with or without botulinum toxin (BoNT) injections, however the results are varying. There are no clinical trials investigating the effects of kinesiology taping in CD patients. The objective of this study is to investigate the efficacy of kinesiology taping as an adjunct to the BoNT injections in patients with CD.</AbstractText>
          <AbstractText Label="METHODS" NlmCategory="METHODS">Twenty-five patients were enrolled to the study. Patients were randomly assigned to the experimental 1 (BoNT + KinesioTaping), experimental 2 (BoNT + ShamTaping) or control (BoNT) treatment. After 12 weeks they were moved to the next experimental group and finally every patient received all 3 proposed treatment options. The severity of CD was quantified with the Toronto Western Spasmodic Torticollis Rating Scale (TWSTRS) including Torticollis severity, Disability, and Pain scales. Quality of life was evaluated using Craniocervical dystonia questionnaire (CDQ4).</AbstractText>
          <AbstractText Label="RESULTS" NlmCategory="RESULTS">In all treatment groups, there was a significant improvement in dystonia symptoms measured with TWSTRS (total score) after BoNT injection regardless of the allocation to the experimental treatment (p &lt; .05). ANOVA analysis revealed no differences in any of the TWSTRS variables after the intervention. Quality of life was significantly improved after application of taping (p &lt; .05, p = .03).</AbstractText>
          <AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">Application of KinesioTaping after BoNT injection provided no additional effect on the severity of dystonia, although the quality of life was improved in patients with CD. Further research investigating the effect of KinesioTaping prior to BoNT injection is required.</AbstractText>
          <CopyrightInformation>© 2022 The Authors. Brain and Behavior published by Wiley Periodicals LLC.</CopyrightInformation>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Dec-Ćwiek</LastName>
            <ForeName>Małgorzata</ForeName>
            <Initials>M</Initials>
            <Identifier Source="ORCID">0000-0002-9829-3301</Identifier>
            <AffiliationInfo>
              <Affiliation>Department of Neurology, Medical College, Jagiellonian University, Krakow, Poland.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Porębska</LastName>
            <ForeName>Karolina</ForeName>
            <Initials>K</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Neurology, Medical College, Jagiellonian University, Krakow, Poland.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Sawczyńska</LastName>
            <ForeName>Katarzyna</ForeName>
            <Initials>K</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Neurology, Medical College, Jagiellonian University, Krakow, Poland.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Kubala</LastName>
            <ForeName>Marcin</ForeName>
            <Initials>M</Initials>
            <AffiliationInfo>
              <Affiliation>Faculty of Medicine and Health Sciences, Andrzej Frycz Modrzewski Krakow University, Krakow, Poland.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Witkowska</LastName>
            <ForeName>Magdalena</ForeName>
            <Initials>M</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Neurology, Medical College, Jagiellonian University, Krakow, Poland.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Zmijewska</LastName>
            <ForeName>Kinga</ForeName>
            <Initials>K</Initials>
            <AffiliationInfo>
              <Affiliation>Faculty of Medicine and Health Sciences, Andrzej Frycz Modrzewski Krakow University, Krakow, Poland.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Department of Orthopedics and Physiotherapy, Medical College, Jagiellonian University, Krakow, Poland.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Antczak</LastName>
            <ForeName>Jakub</ForeName>
            <Initials>J</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Neurology, Medical College, Jagiellonian University, Krakow, Poland.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Pera</LastName>
            <ForeName>Joanna</ForeName>
            <Initials>J</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Neurology, Medical College, Jagiellonian University, Krakow, Poland.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
          <PublicationType UI="D016449">Randomized Controlled Trial</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2022</Year>
          <Month>03</Month>
          <Day>03</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <MedlineTA>Brain Behav</MedlineTA>
        <NlmUniqueID>101570837</NlmUniqueID>
      </MedlineJournalInfo>
      <ChemicalList>
        <Chemical>
          <RegistryNumber>EC 3.4.24.69</RegistryNumber>
          <NameOfSubstance UI="D019274">Botulinum Toxins, Type A</NameOfSubstance>
        </Chemical>
      </ChemicalList>
      <CitationSubset>IM</CitationSubset>
      <MeshHeadingList>
        <MeshHeading>
          <DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D055052" MajorTopicYN="Y">Athletic Tape</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D019274" MajorTopicYN="Y">Botulinum Toxins, Type A</DescriptorName>
          <QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D020821" MajorTopicYN="Y">Dystonic Disorders</DescriptorName>
          <QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D010147" MajorTopicYN="N">Pain Measurement</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D011788" MajorTopicYN="N">Quality of Life</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D014103" MajorTopicYN="Y">Torticollis</DescriptorName>
          <QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D016896" MajorTopicYN="N">Treatment Outcome</DescriptorName>
        </MeshHeading>
      </MeshHeadingList>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="N">botulinum injection</Keyword>
        <Keyword MajorTopicYN="N">botulinum toxin</Keyword>
        <Keyword MajorTopicYN="N">cervical dystonia</Keyword>
        <Keyword MajorTopicYN="N">kinesiotaping</Keyword>
        <Keyword MajorTopicYN="N">neurorehabilitation</Keyword>
      </KeywordList>
      <CoiStatement>The authors declare no potential conflicts of interest with respect to the research, authorship, and/or publication of this article.</CoiStatement>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="revised">
          <Year>2022</Year>
          <Month>1</Month>
          <Day>8</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="received">
          <Year>2021</Year>
          <Month>9</Month>
          <Day>26</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="accepted">
          <Year>2022</Year>
          <Month>2</Month>
          <Day>13</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="pubmed">
          <Year>2022</Year>
          <Month>3</Month>
          <Day>4</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="medline">
          <Year>2022</Year>
          <Month>4</Month>
          <Day>21</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>2022</Year>
          <Month>3</Month>
          <Day>3</Day>
          <Hour>8</Hour>
          <Minute>56</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>ppublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">35238494</ArticleId>
        <ArticleId IdType="pmc">PMC9014990</ArticleId>
        <ArticleId IdType="doi">10.1002/brb3.2541</ArticleId>
      </ArticleIdList>
      <ReferenceList>
        <Reference>
          <Citation>

Albanese, A.
, 
Abbruzzese, G.
, 
Dressler, D.
, 
Duzynski, W.
, 
Khatkova, S.
, 
Marti, M. J.
, 
Mir, P.
, 
Montecucco, C.
, 
Moro, E.
, 
Pinter, M.
, 
Relja, M.
, 
Roze, E.
, 
Skogseid, I. M.
, 
Timerbaeva, S.
, &amp; 
Tzoulis, C.
 (2015). Practical guidance for CD management involving treatment of botulinum toxin: A consensus statement. Journal of Neurology, 262(10), 2201–2213. 10.1007/s00415-015-7703-x
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1007/s00415-015-7703-x</ArticleId>
            <ArticleId IdType="pmc">PMC4608989</ArticleId>
            <ArticleId IdType="pubmed">25877834</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>

Albanese, A.
, 
Asmus, F.
, 
Bhatia, K. P.
, 
Elia, A. E.
, 
Elibol, B.
, 
Filippini, G.
, 
Gasser, T.
, 
Krauss, J. K.
, 
Nardocci, N.
, 
Newton, A.
, &amp; 
Valls‐Solé, J.
 (2011). EFNS guidelines on diagnosis and treatment of primary dystonias. European Journal of Neurology, 18(1), 5–18. 10.1111/j.1468-1331.2010.03042.x
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1111/j.1468-1331.2010.03042.x</ArticleId>
            <ArticleId IdType="pubmed">20482602</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>

Ben‐Shlomo, Y.
 (2002). What are the determinants of quality of life in people with cervical dystonia?
Journal of Neurology, Neurosurgery, and Psychiatry, 72(5), 608–614. 10.1136/jnnp.72.5.608
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1136/jnnp.72.5.608</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>

Bleton, J. ‐P.
 (2010). Physiotherapy of focal dystonia: A physiotherapist's personal experience. European Journal of Neurology, 17(Suppl 1), 107–112. 10.1111/j.1468-1331.2010.03061.x
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1111/j.1468-1331.2010.03061.x</ArticleId>
            <ArticleId IdType="pubmed">20590817</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Botox (onabotulinumtoxinA). Full prescribing information. https://allergan‐web‐cdn‐prod.azureedge.net. Accessed April 2021.</Citation>
        </Reference>
        <Reference>
          <Citation>

Boyce, M. J.
, 
Canning, C. G.
, 
Mahant, N.
, 
Morris, J.
, 
Latimer, J.
, &amp; 
Fung, V. S.
 (2013). Active exercise for individuals with cervical dystonia: A pilot randomized controlled trial. Clinical Rehabilitation, 27(3), 226–235. 10.1177/0269215512456221
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1177/0269215512456221</ArticleId>
            <ArticleId IdType="pubmed">22904115</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>

Bressman, S. B.
, &amp; 
Greene, P. E.
 (2000). Dystonia. Current Treatment Options in Neurology, 2(3), 275–285. 10.1007/s11940-000-0009-y
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1007/s11940-000-0009-y</ArticleId>
            <ArticleId IdType="pubmed">11096754</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>

Chan, J.
, 
Brin, M. F.
, &amp; 
Fahn, S.
 (1991). Idiopathic cervical dystonia: Clinical characteristics. Movement Disorders, 6(2), 119–126. 10.1002/mds.870060206
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1002/mds.870060206</ArticleId>
            <ArticleId IdType="pubmed">2057004</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>

Comella, C.
, 
Ferreira, J. J.
, 
Pain, E.
, 
Azoulai, M.
, &amp; 
Om, S.
 (2021). Patient perspectives on the therapeutic profile of botulinum neurotoxin type A in cervical dystonia. Journal of Neurology, 268(3), 903–912. 10.1007/s00415-020-10217-7
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1007/s00415-020-10217-7</ArticleId>
            <ArticleId IdType="pmc">PMC7914227</ArticleId>
            <ArticleId IdType="pubmed">32939574</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>

Counsell, C.
, 
Sinclair, H.
, 
Fowlie, J.
, 
Tyrrell, E.
, 
Derry, N.
, 
Meager, P.
, 
Norrie, J.
, &amp; 
Grosset, D.
 (2016). A randomized trial of specialized versus standard neck physiotherapy in cervical dystonia. Parkinsonism &amp; Related Disorders, 23, 72–79. 10.1016/j.parkreldis.2015.12.010
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.parkreldis.2015.12.010</ArticleId>
            <ArticleId IdType="pubmed">26723272</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>

Crowner, B. E.
 (2007). Cervical dystonia: Disease profile and clinical management. Physical Therapy, 87(11), 1511–1526. 10.2522/ptj.20060272
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.2522/ptj.20060272</ArticleId>
            <ArticleId IdType="pubmed">17878433</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>

De Pauw, J.
, 
Van Der Velden, K.
, 
Meirte, J.
, 
Van Daele, U.
, 
Truijen, S.
, 
Cras, P.
, 
Mercelis, R.
, &amp; 
De Hertogh, W.
 (2014). The effectiveness of physiotherapy for cervical dystonia: A systematic literature review. Journal of Neurology, 261(10), 1857–1865. 10.1007/s00415-013-7220-8
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1007/s00415-013-7220-8</ArticleId>
            <ArticleId IdType="pubmed">24413637</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Dysport (abobotulinumtoxinA). Full prescribing information. http://www.ipsen.com. Accessed November 2018.</Citation>
        </Reference>
        <Reference>
          <Citation>

Edwards, M. J.
, 
Huang, Y.‐Z.
, 
Mir, P.
, 
Rothwell, J. C.
, &amp; 
Bhatia, K. P.
 (2006). Abnormalities in motor cortical plasticity differentiate manifesting and nonmanifesting DYT1 carriers. Movement Disorders, 21(12), 2181–2186. 10.1002/mds.21160
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1002/mds.21160</ArticleId>
            <ArticleId IdType="pubmed">17078060</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>

Finsterer, J.
, 
Maeztu, C.
, 
Revuelta, G. J.
, 
Reichel, G.
, &amp; 
Truong, D.
 (2015). Collum‐caput (COL‐CAP) concept for conceptual anterocollis, anterocaput, and forward sagittal shift. Journal of the Neurological Sciences, 355(1‐2), 37–43. 10.1016/j.jns.2015.06.015
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.jns.2015.06.015</ArticleId>
            <ArticleId IdType="pubmed">26088286</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>

Francisco, G.
, 
Balbert, A.
, 
Bavikatte, G.
, 
Bensmail, D.
, 
Carda, S.
, 
Deltombe, T.
, 
Draulans, N.
, 
Escaldi, S.
, 
Gross, R.
, 
Jacinto, J.
, 
Ketchum, N.
, 
Molteni, F.
, 
Perez, S.
, 
O'Dell, M.
, 
Reebye, R.
, 
Säterö, P.
, 
Verduzco‐Gutierrez, M.
, 
Walker, H.
, &amp; 
Wissel, J.
 (2021). A practical guide to optimizing the benefits of post‐stroke spasticity interventions with botulinum toxin A: An international group consensus. Journal of Rehabilitation Medicine, 53(1), jrm00134. 10.2340/16501977-2753
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.2340/16501977-2753</ArticleId>
            <ArticleId IdType="pmc">PMC8772370</ArticleId>
            <ArticleId IdType="pubmed">33057730</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>

Giray, E.
, 
Karadag‐Saygi, E.
, 
Mansiz‐Kaplan, B.
, 
Tokgoz, D.
, 
Bayindir, O.
, &amp; 
Kayhan, O.
 (2017). A randomized, single‐blinded pilot study evaluating the effects of kinesiology taping and the tape application techniques in addition to therapeutic exercises in the treatment of congenital muscular torticollis. Clinical Rehabilitation, 31(8), 1098–1106. 10.1177/0269215516673885
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1177/0269215516673885</ArticleId>
            <ArticleId IdType="pubmed">27733650</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>

Greene, P.
, 
Kang, U.
, 
Fahn, S.
, 
Brin, M.
, 
Moskowitz, C.
, &amp; 
Flaster, E.
 (1990). Double‐blind, placebo‐controlled trial of botulinum toxin injections for the treatment of spasmodic torticollis. Neurology, 40(8), 1213–1218. 10.1212/WNL.40.8.1213
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1212/WNL.40.8.1213</ArticleId>
            <ArticleId IdType="pubmed">2199847</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>

Halseth, T.
, 
McChesney, J. W.
, 
Debeliso, M.
, 
Vaughn, R.
, &amp; 
Lien, J.
 (2004). The effects of kinesio taping on proprioception at the ankle. Journal of Sports Science and Medicine, 3(1), 1–7.</Citation>
        </Reference>
        <Reference>
          <Citation>

Hu, W.
, 
Rundle‐Gonzalez, V.
, 
Kulkarni, S. J.
, 
Martinez‐Ramirez, D.
, 
Almeida, L.
, 
Okun, M. S.
, &amp; 
Wagle Shukla, A.
 (2019). A randomized study of botulinum toxin versus botulinum toxin plus physical therapy for treatment of cervical dystonia. Parkinsonism &amp; Related Disorders, 63, 195–198. 10.1016/j.parkreldis.2019.02.035
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.parkreldis.2019.02.035</ArticleId>
            <ArticleId IdType="pubmed">30837195</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>

Jankovic, J.
 (2006). Treatment of dystonia. Lancet Neurology, 5(10), 864–872. 10.1016/S1474-4422(06)70574-9
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/S1474-4422(06)70574-9</ArticleId>
            <ArticleId IdType="pubmed">16987733</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>

Karadag‐Saygi, E.
, 
Cubukcu‐Aydoseli, K.
, 
Kablan, N.
, &amp; 
Ofluoglu, D.
 (2010). The role of kinesiotaping combined with botulinum toxin to reduce plantar flexors spasticity after stroke. Topics in Stroke Rehabilitation, 17(4), 318–322. 10.1310/tsr1704-318
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1310/tsr1704-318</ArticleId>
            <ArticleId IdType="pubmed">20826420</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>

Klingelhoefer, L.
, 
Martino, D.
, 
Martinez‐Martin, P.
, 
Sauerbier, A.
, 
Rizos, A.
, 
Jost, W.
, 
Warner, T. T.
, &amp; 
Chaudhuri, K. R.
 (2014). Nonmotor symptoms and focal cervical dystonia: Observations from 102 patients. Basal Ganglia, 4, 117–120. 10.1016/j.baga.2014.10.002
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.baga.2014.10.002</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>

Kase, K.
 (2016). Clinical therapeutic application of the KinesioTaping methods. Japan: Ikai Co Ltd.</Citation>
        </Reference>
        <Reference>
          <Citation>

Kojovic, M.
, 
Caronni, A.
, 
Bologna, M.
, 
Rothwell, J. C.
, 
Bhatia, K. P.
, &amp; 
Edwards, M. J.
 (2011). Botulinum toxin injections reduce associative plasticity in patients with primary dystonia. Movement Disorders, 26(7), 1282–1289. 10.1002/mds.23681
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1002/mds.23681</ArticleId>
            <ArticleId IdType="pmc">PMC4235250</ArticleId>
            <ArticleId IdType="pubmed">21469207</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>

Muller, J.
, 
Kemmler, G.
, &amp; 
Wissel, J.
 et al. (2002).The impact of blepharospasm and cervical dystonia on health‐related quality of life and depression. Journal of Neurology, 249(7), 842–846.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">12140667</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>

Pekmezovic, T.
, 
Svetel, M.
, 
Ivanovic, N.
, 
Dragasevic, N.
, 
Petrovic, I.
, 
Tepavcevic, D. K.
, &amp; 
Kostic, V. S.
 (2009). Quality of life in patients with focal dystonia. Clinical Neurology and Neurosurgery, 111(2), 161–164. 10.1016/j.clineuro.2008.09.023
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.clineuro.2008.09.023</ArticleId>
            <ArticleId IdType="pubmed">18995953</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>

Pelosin, E.
, 
Avanzino, L.
, 
Marchese, R.
, 
Stramesi, P.
, 
Bilanci, M.
, 
Trompetto, C.
, &amp; 
Abbruzzese, G.
 (2013). Kinesiotaping reduces pain and modulates sensory function in patients with focal dystonia: A randomized crossover pilot study. Neural Repair, 27(8), 722–731. 10.1177/1545968313491010
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1177/1545968313491010</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>

Poewe, W.
, 
Burbaud, P.
, 
Castelnovo, G.
, 
Jost, W. H.
, 
Ceballos‐Baumann, A. O.
, 
Banach, M.
, 
Potulska‐Chromik, A.
, 
Ferreira, J. J.
, 
Bihari, K.
, 
Ehler, E.
, 
Bares, M.
, 
Dzyak, L. A.
, 
Belova, A. N.
, 
Pham, E.
, 
Liu, W. J.
, &amp; 
Picaut, P.
 (2016). Efficacy and safety of abobotulinumtoxinA liquid formulation in cervical dystonia: A randomized‐controlled trial. Movement Disorders, 31(11), 1649–1657. 10.1002/mds.26760
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1002/mds.26760</ArticleId>
            <ArticleId IdType="pubmed">27653448</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>

Poewe, W.
, 
Deuschl, G.
, 
Nebe, A.
, 
Feifel, E.
, 
Wissel, J.
, 
Benecke, R.
, 
Kessler, K. R.
, 
Ceballos‐Baumann, A. O.
, 
Ohly, A.
, 
Oertel, W.
, &amp; 
Kunig, G.
 (1998). What is the optimal dose of botulinum toxin A in the treatment of cervical dystonia? Results of a double blind, placebo controlled, dose ranging study using Dysport. German Dystonia Study Group. Journal of Neurology, Neurosurgery, and Psychiatry, 64(1), 13–17. 10.1136/jnnp.64.1.13
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1136/jnnp.64.1.13</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>

Reichel, G.
 (2011). Cervical dystonia: A new phenomenological classification for botulinum toxin therapy. Basal Ganglia, 1(1), 5–12. 10.1016/j.baga.2011.01.001
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.baga.2011.01.001</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>

Quartarone, A.
 (2003). Abnormal associative plasticity of the human motor cortex in writer's cramp. Brain, 126(Pt 12), 2586–2596. 10.1093/brain/awg273
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1093/brain/awg273</ArticleId>
            <ArticleId IdType="pubmed">14506068</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>

Reiter, F.
, 
Danni, M.
, 
Lagalla, G.
, 
Ceravolo, G.
, &amp; 
Provinciali, L.
 (1998). Low‐dose botulinum toxin with ankle taping for the treatment of spastic equinovarus foot after stroke. Archives of Physical Medicine and Rehabilitation, 79(5), 532–535. 10.1016/S0003-9993(98)90068-5
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/S0003-9993(98)90068-5</ArticleId>
            <ArticleId IdType="pubmed">9596394</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>

Simpson, D. M.
, 
Hallett, M.
, 
Ashman, E. J.
, 
Comella, C. L.
, 
Green, M. W.
, 
Gronseth, G. S.
, 
Armstrong, M. J.
, 
Gloss, D.
, 
Potrebic, S.
, 
Jankovic, J.
, 
Karp, B. P.
, 
Naumann, M.
, 
So, Y. T.
, &amp; 
Yablon, S. A.
 (2016). Practice guideline update summary: Botulinum neurotoxin for the treatment of blepharospasm, cervical dystonia, adult spasticity, and headache. Neurology, 86, 1818–1826. 10.1212/WNL.0000000000002560
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1212/WNL.0000000000002560</ArticleId>
            <ArticleId IdType="pmc">PMC4862245</ArticleId>
            <ArticleId IdType="pubmed">27164716</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Smania N., Corato E., Tinazzi M., 
Montagnana, B.
, 
Fiaschi, A.
, &amp; 
Aglioti, S. M.
 (2003). The effect of two different rehabilitation treatments in cervical dystonia: Preliminary results in four patients. Functional Neurology, 18(4), 219–225.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">15055747</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>

Tassorelli, C.
, 
Mancini, F.
, 
Balloni, L.
, 
Pacchetti, C.
, 
Sandrini, G.
, 
Nappi, G.
, &amp; 
Martignoni, E.
 (2006). Botulinum toxin and neuromotor rehabilitation: An integrated approach to idiopathic cervical dystonia. Movement Disorders, 21(12), 2240–2243. 10.1002/mds.21145
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1002/mds.21145</ArticleId>
            <ArticleId IdType="pubmed">17029278</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>

Tatu, L.
, &amp; 
Jost, W. H.
 (2007). Anatomy and cervical dystonia: “Dysfunction follows form. Journal of Neural Transmission, 124(2), 237–243. 10.1007/s00702-016-1621-7
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1007/s00702-016-1621-7</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>

Van Den Dool, J.
, 
Tijssen, M. A. J.
, 
Koelman, J. H. T. M.
, 
Engelbert, R. H. H.
, &amp; 
Visser, B.
 (2016). Determinants of disability in cervical dystonia. Parkinsonism &amp; Related Disorders, 32, 48–53. 10.1016/j.parkreldis.2016.08.014
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.parkreldis.2016.08.014</ArticleId>
            <ArticleId IdType="pubmed">27553512</ArticleId>
          </ArticleIdList>
        </Reference>
      </ReferenceList>
    </PubmedData>
  </PubmedArticle>
</PubmedArticleSet>
